News

Pfizer and its German partner BioNTech on Friday lost their bid to overturn a ruling that their COVID-19 vaccine infringed ...
US health and human services secretary Robert F Kennedy Jr announced Tuesday the US federal government is canceling around $500 million worth of vaccine development projects using mRNA technology.The ...
Pfizer delivered a strong Q2 earnings beat, raising FY2025 guidance and demonstrating effective cost-cutting. Learn why PFE ...
Pfizer said its full-year profit should benefit from cost cuts across its research and manufacturing operations after posting ...
Pfizer and its German partner BioNTech on Friday lost their bid to overturn a ruling that their COVID-19 vaccine infringed ...
The US Department of Health and Human Services (HHS) plans to cancel $500m (£376m) in funding for mRNA vaccines being ...
The Health and Human Services secretary cancelled nearly $500 million in contracts related to the development of future ...
Investor sentiment has been adversely affected by worries regarding the company’s drug pipeline. Nonetheless, we believe PFE ...
The researchers followed participants from October 2024 to January 2025. Median age was 76 years, and 54.2% were women. By ...
This marks US Health Secretary Robert F. Kennedy Jr’s latest effort to weave vaccine scepticism into US policy. Read more at ...
Pfizer Inc.’s stock was rallying Tuesday after the drug giant lifted its 2025 adjusted profit estimate, on the heels of a 10% ...
Pfizer stock (PFE: NYSE) surged on Tuesday after the company delivered stronger-than-expected second-quarter results and lifted its profit outlook for the year. Revenue climbed 10% to $14.7 billion, ...